Free Trial

Portage Biotech (PRTG) SEC Filings & 10K Form

Portage Biotech logo
$4.11 +0.01 (+0.24%)
As of 04:00 PM Eastern

Recent Portage Biotech SEC Filings

DateFilerForm TypeView
01/06/2025
5:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/06/2025
5:12 AM
Portage Biotech (Filer)
Form 424B3
12/19/2024
3:43 PM
Mellon James (Filed by)
Portage Biotech (Subject)
Form SCHEDULE 13D/A
12/17/2024
6:05 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
6:11 AM
Portage Biotech (Filer)
Form 424B3
12/13/2024
3:35 PM
Portage Biotech (Filer)
Form 424B3
12/13/2024
3:15 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
4:01 PM
Portage Biotech (Filer)
Form 424B3
12/12/2024
3:30 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2024
3:35 PM
Portage Biotech (Filer)
Form 424B3
12/05/2024
3:28 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
3:47 PM
Portage Biotech (Filer)
Form 424B3
11/26/2024
3:25 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
3:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Portage Biotech (Subject)
Form SC 13G/A
10/04/2024
3:30 PM
Portage Biotech (Filer)
Form 424B3
10/04/2024
3:15 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2024
8:18 PM
Portage Biotech (Subject)
Shaw Allan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
3:28 PM
Portage Biotech (Subject)
Shaw Allan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
8:41 AM
MINTZ STEVEN (Reporting)
Portage Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
10:25 AM
Bailey Gregory (Reporting)
Portage Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
11:15 PM
Portage Biotech (Filer)
Form EFFECT
08/27/2024
7:30 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:05 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:11 AM
Portage Biotech (Filer)
Form 424B3
08/15/2024
7:31 AM
Portage Biotech (Filer)
Form 424B3
08/15/2024
7:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
4:29 PM
Portage Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
08/13/2024
7:52 AM
Portage Biotech (Filer)
Form 424B3
08/13/2024
7:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
3:31 PM
Portage Biotech (Filer)
Form 424B3
04/12/2024
4:21 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
4:22 PM
Portage Biotech (Filer)
Form 424B3
03/08/2024
4:30 PM
Portage Biotech (Filer)
Form 424B3
03/08/2024
4:04 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
8:11 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
8:36 PM
Portage Biotech (Filer)
Form 424B3
02/28/2024
4:19 PM
Portage Biotech (Filer)
Form 424B3
02/14/2024
2:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Portage Biotech (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PRTG) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners